Genetics Generation Advancement (ROCO:4160) Accounts Payable & Accrued Expense : NT$118.5 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Genetics Generation Advancement Accounts Payable & Accrued Expense?

Genetics Generation Advancement's quarterly accounts payable & accrued expense declined from Sep. 2024 (NT$133.2 Mil) to Dec. 2024 (NT$119.0 Mil) and declined from Dec. 2024 (NT$119.0 Mil) to Mar. 2025 (NT$118.5 Mil).

Genetics Generation Advancement's annual accounts payable & accrued expense increased from Dec. 2022 (NT$92.8 Mil) to Dec. 2023 (NT$106.6 Mil) and increased from Dec. 2023 (NT$106.6 Mil) to Dec. 2024 (NT$119.0 Mil).

Genetics Generation Advancement Accounts Payable & Accrued Expense Historical Data

The historical data trend for Genetics Generation Advancement's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetics Generation Advancement Accounts Payable & Accrued Expense Chart

Genetics Generation Advancement Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

60.74

82.13

92.83

106.61

118.99

Genetics Generation Advancement Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															108.55	123.05	133.21	118.99	118.49

Genetics Generation Advancement Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Genetics Generation Advancement Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetics Generation Advancement Corp (ROCO:4160) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494

Website

https://www.gga.asia

Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.

Genetics Generation Advancement Headlines

No Headlines